COVID-19: Herd Immunity Study in the Czech Republic (SARSCoV2CZPrev)
Herd Immunity Study SARS-CoV-2-CZ-Preval
Sponsor: Brno University Hospital
A observational or N/A phase clinical study on COVID and SARS-CoV 2, this trial is completed. The trial is conducted by Brno University Hospital and has accumulated 11 data snapshots since 2020. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
11 versions recorded-
Dec 2025 — Present [monthly]
Completed
-
Sep 2024 — Dec 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Nov 2022 — Jul 2024 [monthly]
Completed
-
May 2022 — Nov 2022 [monthly]
Completed
▶ Show 6 earlier versions
-
Dec 2021 — May 2022 [monthly]
Completed
-
Oct 2021 — Dec 2021 [monthly]
Completed
-
Jan 2021 — Oct 2021 [monthly]
Completed
-
Nov 2020 — Jan 2021 [monthly]
Completed
-
Jul 2020 — Nov 2020 [monthly]
Completed
-
Jun 2020 — Jul 2020 [monthly]
Completed
First recorded
Apr 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Brno University Hospital
- Charles University, Czech Republic
- Czech Academy of Sciences
- Czech Statistical Office
- Faculty of Health Studies, J. E. Purkyně University in Ústí nad Labem
- Faculty of Military Health Sciences, University of Defence in Brno
- General University Hospital, Prague
- Institute for Clinical and Experimental Medicine
- Institute of Health Information and Statistics of the Czech Republic
- Krajská zdravotní, a.s., Ústí nad Labem Region Hospitals
- Masaryk Memorial Cancer Institute
- Masaryk University
- Military University Hospital, Prague
- Ministry of Health, Czech Republic
- Palacky University
- University Hospital Olomouc
- University of Ostrava
For direct contact, visit the study record on ClinicalTrials.gov .